Evidence map›Paper›PMID 30231884›Full record

ArticleRadiation oncology (London, England)2018

Correction to: ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial.

Thomas Zilli, Marta Scorsetti, Daniel Zwahlen, Ciro Franzese, Robert Förster, Niccolò Giaj-Levra, Nikolaos Koutsouvelis, Aurelie Bertaut, Michel Zimmermann, Giuseppe Roberto D'Agostino and 3 more

Abstract readPublished Erratum
In one paragraph

Article in Radiation oncology (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Thomas ZilliRadiation Oncology, Geneva University Hospital, CH-1211, 14, Geneva, Switzerland. Thomas.Zilli@hcuge.ch.
Marta ScorsettiRadiation Oncology, Humanitas University, Rozzano, Milan, Italy.
Daniel ZwahlenRadiation Oncology, Kantonsspital Graubünden, Chur, Switzerland.
Ciro FranzeseRadiation Oncology, Humanitas Research Hospital and Cancer Center, Rozzano, Milan, Italy.
Robert FörsterRadiation Oncology, University Hospital Zürich, Zürich, Switzerland.
Niccolò Giaj-LevraRadiation Oncology, Sacro Cuore Don-Calabria, Negrar, Italy.
Nikolaos KoutsouvelisRadiation Oncology, Geneva University Hospital, CH-1211, 14, Geneva, Switzerland.
Aurelie BertautMethodology and biostatistic unit, Centre Georges François Leclerc, Dijon, France.
Michel ZimmermannRadiation Oncology, Kantonsspital Graubünden, Chur, Switzerland.
Giuseppe Roberto D'AgostinoRadiation Oncology, Humanitas Research Hospital and Cancer Center, Rozzano, Milan, Italy.
Filippo AlongiRadiation Oncology, Sacro Cuore Don-Calabria, Negrar, Italy.
Matthias GuckenbergerRadiation Oncology, University Hospital Zürich, Zürich, Switzerland.
Raymond MiralbellRadiation Oncology, Geneva University Hospital, CH-1211, 14, Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following publication of the original article [1], the authors reported that one of the authors' names is spelled incorrectly. In this Correction the incorrect and correct author name are shown. The original publication of this article has been corrected.

Identifiers

PMID30231884
PMCPMC6145342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.